{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:29:43Z","timestamp":1779334183233,"version":"3.51.4"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["KM281100126"],"award-info":[{"award-number":["KM281100126"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011634","name":"TAU | Varda and Boaz Dotan Research Center for Hemato-Oncology Research, Tel Aviv University","doi-asserted-by":"publisher","award":["0601243683"],"award-info":[{"award-number":["0601243683"]}],"id":[{"id":"10.13039\/501100011634","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogenesis"],"DOI":"10.1038\/s41389-025-00554-5","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T04:09:45Z","timestamp":1744344585000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Myeloma mesenchymal stem cells\u2019 bioenergetics afford a novel selective therapeutic target"],"prefix":"10.1038","volume":"14","author":[{"given":"Oded","family":"Komemi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elina","family":"Orbuch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osnat","family":"Jarchowsky-Dolberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaron Shraga","family":"Brin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelly","family":"Tartakover-Matalon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Metsada","family":"Pasmanik-Chor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Lishner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7151-4610","authenticated-orcid":false,"given":"Liat","family":"Drucker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"key":"554_CR1","volume":"2018","author":"J Wu","year":"2018","unstructured":"Wu J, Zhang W, Ran Q, Xiang Y, Zhong JF, Li SC, et al. The differentiation balance of bone marrow mesenchymal stem cells is crucial to hematopoiesis. Stem Cells Int. 2018;2018:1540148.","journal-title":"Stem Cells Int"},{"key":"554_CR2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4252\/wjsc.v15.i5.421","volume":"15","author":"D Garc\u00eda-S\u00e1nchez","year":"2023","unstructured":"Garc\u00eda-S\u00e1nchez D, Gonz\u00e1lez-Gonz\u00e1lez A, Alfonso-Fern\u00e1ndez A, Del Dujo-Guti\u00e9rrez M, P\u00e9rez-Campo FM. Communication between bone marrow mesenchymal stem cells and multiple myeloma cells: impact on disease progression. World J Stem Cells. 2023;15:421\u201337.","journal-title":"World J Stem Cells"},{"key":"554_CR3","doi-asserted-by":"crossref","unstructured":"Maiso P, Mogoll\u00f3n P, Ocio EM, Garayoa M. Bone marrow mesenchymal stromal cells in multiple myeloma: their role as active contributors to myeloma progression. Cancers (Basel). 2021;13.","DOI":"10.3390\/cancers13112542"},{"key":"554_CR4","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/mc.22378","volume":"55","author":"O Attar-Schneider","year":"2016","unstructured":"Attar-Schneider O, Zismanov V, Dabbah M, Tartakover-Matalon S, Drucker L, Lishner M. Multiple myeloma and bone marrow mesenchymal stem cells\u2019 crosstalk: effect on translation initiation. Mol Carcinog. 2016;55:1343\u201354.","journal-title":"Mol Carcinog"},{"key":"554_CR5","volume":"18","author":"HA Tirado","year":"2023","unstructured":"Tirado HA, Balasundaram N, Laaouimir L, Erdem A, van Gastel N. Metabolic crosstalk between stromal and malignant cells in the bone marrow niche. Bone Rep. 2023;18:101669.","journal-title":"Bone Rep"},{"key":"554_CR6","doi-asserted-by":"crossref","unstructured":"Gavriatopoulou M, Paschou SA, Ntanasis-Stathopoulos I, Dimopoulos MA. Metabolic disorders in multiple myeloma. Int J Mol Sci 2021;22.","DOI":"10.3390\/ijms222111430"},{"key":"554_CR7","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1038\/s41388-022-02398-4","volume":"41","author":"Y Cheng","year":"2022","unstructured":"Cheng Y, Sun F, Thornton K, Jing X, Dong J, Yun G, et al. FOXM1 regulates glycolysis and energy production in multiple myeloma. Oncogene. 2022;41:3899\u2013911.","journal-title":"Oncogene"},{"key":"554_CR8","doi-asserted-by":"crossref","unstructured":"Lim JSL, Chong PSY, Chng WJ. Metabolic vulnerabilities in multiple myeloma. Cancers (Basel). 2022;14.","DOI":"10.3390\/cancers14081905"},{"key":"554_CR9","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41590-021-00931-3","volume":"22","author":"MME de Jong","year":"2021","unstructured":"de Jong MME, Kellermayer Z, Papazian N, Tahri S, Hofste Op Bruinink D, Hoogenboezem R, et al. The multiple myeloma microenvironment is defined by an inflammatory stromal cell landscape. Nat Immunol. 2021;22:769\u201380.","journal-title":"Nat Immunol"},{"key":"554_CR10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10555-022-10069-9","volume":"42","author":"N Plakhova","year":"2023","unstructured":"Plakhova N, Panagopoulos V, Vandyke K, Zannettino ACW, Mrozik KM. Mesenchymal stromal cell senescence in haematological malignancies. Cancer Metastasis Rev. 2023;42:277\u201396.","journal-title":"Cancer Metastasis Rev"},{"key":"554_CR11","doi-asserted-by":"crossref","unstructured":"Liu Z, Liu H, He J, Lin P, Tong Q, Yang J. Myeloma cells shift osteoblastogenesis to adipogenesis by inhibiting the ubiquitin ligase MURF1 in mesenchymal stem cells. Sci Signal 2020;13.","DOI":"10.1126\/scisignal.aay8203"},{"key":"554_CR12","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/s41375-018-0061-9","volume":"32","author":"S Xu","year":"2018","unstructured":"Xu S, De Veirman K, De Becker A, Vanderkerken K, Van Riet I. Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?. Leukemia. 2018;32:1500\u201314.","journal-title":"Leukemia"},{"key":"554_CR13","doi-asserted-by":"crossref","first-page":"1000106","DOI":"10.3389\/fonc.2022.1000106","volume":"12","author":"R Nair","year":"2022","unstructured":"Nair R, Gupta P, Shanmugam M. Mitochondrial metabolic determinants of multiple myeloma growth, survival, and therapy efficacy. Frontiers Oncol. 2022;12:1000106.","journal-title":"Frontiers Oncol"},{"key":"554_CR14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.tcb.2022.08.001","volume":"33","author":"DC Altieri","year":"2023","unstructured":"Altieri DC. Mitochondria in cancer: clean windmills or stressed tinkerers?. Trends Cell Biol. 2023;33:293\u20139.","journal-title":"Trends Cell Biol"},{"key":"554_CR15","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100067R","volume":"35","author":"M Adebayo","year":"2021","unstructured":"Adebayo M, Singh S, Singh AP, Dasgupta S. Mitochondrial fusion and fission: the fine-tune balance for cellular homeostasis. Faseb j. 2021;35:e21620.","journal-title":"Faseb j"},{"key":"554_CR16","doi-asserted-by":"crossref","unstructured":"Tibullo D, Giallongo C, Romano A, Vicario N, Barbato A, Puglisi F, et al. Mitochondrial functions, energy metabolism and protein glycosylation are interconnected processes mediating resistance to Bortezomib in multiple myeloma cells. Biomolecules. 2020;10.","DOI":"10.3390\/biom10050696"},{"key":"554_CR17","doi-asserted-by":"crossref","unstructured":"Liang L, Li W, Li X, Jin X, Liao Q, Li Y, et al. \u2018Reverse Warburg effect\u2019 of cancer\u2011associated fibroblasts (Review). Int J Oncol. 2022;60.","DOI":"10.3892\/ijo.2022.5357"},{"key":"554_CR18","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1158\/0008-5472.CAN-18-0773","volume":"79","author":"CR Marlein","year":"2019","unstructured":"Marlein CR, Piddock RE, Mistry JJ, Zaitseva L, Hellmich C, Horton RH, et al. CD38-driven mitochondrial trafficking promotes bioenergetic plasticity in multiple myeloma. Cancer Res. 2019;79:2285\u201397.","journal-title":"Cancer Res"},{"key":"554_CR19","doi-asserted-by":"crossref","DOI":"10.1038\/s41389-022-00380-z","volume":"11","author":"C Giallongo","year":"2022","unstructured":"Giallongo C, Dulcamare I, Tibullo D, Del Fabro V, Vicario N, Parrinello N, et al. CXCL12\/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment. Oncogenesis. 2022;11:6.","journal-title":"Oncogenesis"},{"key":"554_CR20","doi-asserted-by":"crossref","unstructured":"Huang G, Li H, Zhang H. Abnormal expression of mitochondrial ribosomal proteins and their encoding genes with cell apoptosis and diseases. Int J Mol Sci. 2020;21.","DOI":"10.3390\/ijms21228879"},{"key":"554_CR21","volume":"164","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wang P, Hu W, Chen D. New insights into the roles of peroxiredoxins in cancer. Biomed Pharmacother. 2023;164:114896.","journal-title":"Biomed Pharmacother"},{"key":"554_CR22","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13408","volume":"20","author":"TR Richman","year":"2021","unstructured":"Richman TR, Ermer JA, Siira SJ, Kuznetsova I, Brosnan CA, Rossetti G, et al. Mitochondrial mistranslation modulated by metabolic stress causes cardiovascular disease and reduced lifespan. Aging Cell. 2021;20:e13408.","journal-title":"Aging Cell"},{"key":"554_CR23","doi-asserted-by":"crossref","first-page":"13106","DOI":"10.1096\/fj.202000767R","volume":"34","author":"P Marchetti","year":"2020","unstructured":"Marchetti P, Fovez Q, Germain N, Khamari R, Kluza J. Mitochondrial spare respiratory capacity: Mechanisms, regulation, and significance in non-transformed and cancer cells. Faseb j. 2020;34:13106\u201324.","journal-title":"Faseb j"},{"key":"554_CR24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.immuni.2011.12.007","volume":"36","author":"GJ van der Windt","year":"2012","unstructured":"van der Windt GJ, Everts B, Chang CH, Curtis JD, Freitas TC, Amiel E, et al. Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity. 2012;36:68\u201378.","journal-title":"Immunity"},{"key":"554_CR25","volume":"17","author":"JM Su\u00e1rez-Rivero","year":"2022","unstructured":"Su\u00e1rez-Rivero JM, Pastor-Maldonado CJ, Povea-Cabello S, \u00c1lvarez-C\u00f3rdoba M, Villal\u00f3n-Garc\u00eda I, Talaver\u00f3n-Rey M, et al. UPR(mt) activation improves pathological alterations in cellular models of mitochondrial diseases. Orphanet J Rare Dis. 2022;17:204.","journal-title":"Orphanet J Rare Dis"},{"key":"554_CR26","doi-asserted-by":"crossref","first-page":"102613","DOI":"10.1016\/j.redox.2023.102613","volume":"60","author":"R Zhang","year":"2023","unstructured":"Zhang R, Zhang K. Mitochondrial NAD kinase in health and disease. Redox Biol. 2023;60:102613.","journal-title":"Redox Biol"},{"key":"554_CR27","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41416-020-0778-x","volume":"122","author":"W Dai","year":"2020","unstructured":"Dai W, Wang G, Chwa J, Oh ME, Abeywardana T, Yang Y, et al. Mitochondrial division inhibitor (mdivi-1) decreases oxidative metabolism in cancer. Br J Cancer. 2020;122:1288\u201397.","journal-title":"Br J Cancer"},{"key":"554_CR28","doi-asserted-by":"crossref","first-page":"111818","DOI":"10.1016\/j.celrep.2022.111818","volume":"41","author":"DT Sessions","year":"2022","unstructured":"Sessions DT, Kim KB, Kashatus JA, Churchill N, Park KS, Mayo MW, et al. Opa1 and Drp1 reciprocally regulate cristae morphology, ETC function, and NAD(+) regeneration in KRas-mutant lung adenocarcinoma. Cell Rep. 2022;41:111818.","journal-title":"Cell Rep"},{"key":"554_CR29","doi-asserted-by":"crossref","unstructured":"Je\u017eek J, Cooper KF, Strich R. Reactive oxygen species and mitochondrial dynamics: the Yin and Yang of mitochondrial dysfunction and cancer progression. Antioxidants (Basel). 2018;7.","DOI":"10.3390\/antiox7010013"},{"key":"554_CR30","doi-asserted-by":"crossref","unstructured":"Lasica M. Anderson MA. Review of Venetoclax in CLL, AML and multiple myeloma. J Pers Med. 2021;11.","DOI":"10.3390\/jpm11060463"},{"key":"554_CR31","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1111\/cas.15073","volume":"112","author":"A Kitadate","year":"2021","unstructured":"Kitadate A, Terao T, Narita K, Ikeda S, Takahashi Y, Tsushima T, et al. Multiple myeloma with t(11;14)-associated immature phenotype has lower CD38 expression and higher BCL2 dependence. Cancer Sci. 2021;112:3645\u201354.","journal-title":"Cancer Sci"},{"key":"554_CR32","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1182\/blood.2020007899","volume":"137","author":"VA Gupta","year":"2021","unstructured":"Gupta VA, Barwick BG, Matulis SM, Shirasaki R, Jaye DL, Keats JJ, et al. Venetoclax sensitivity in multiple myeloma is associated with B-cell gene expression. Blood. 2021;137:3604\u201315.","journal-title":"Blood"},{"key":"554_CR33","doi-asserted-by":"crossref","unstructured":"Chow S, Kis O, Mulder DT, Danesh A, Bruce J, Wang TT, et al. Myeloma immunoglobulin rearrangement and translocation detection through targeted capture sequencing. Life Sci Alliance. 2023;6.","DOI":"10.26508\/lsa.202201543"},{"key":"554_CR34","doi-asserted-by":"crossref","unstructured":"Algarin EM, Quwaider D, Campos-Laborie FJ, Diaz-Tejedor A, Mogollon P, Vuelta E, et al. Stroma-mediated resistance to S63845 and Venetoclax through MCL-1 and BCL-2 expression changes induced by miR-193b-3p and miR-21-5p dysregulation in multiple myeloma. Cells 2021;10.","DOI":"10.3390\/cells10030559"},{"key":"554_CR35","doi-asserted-by":"crossref","first-page":"101450","DOI":"10.1016\/j.molmet.2022.101450","volume":"58","author":"K Ning","year":"2022","unstructured":"Ning K, Liu S, Yang B, Wang R, Man G, Wang DE, et al. Update on the effects of energy metabolism in bone marrow mesenchymal stem cells differentiation. Mol Metab. 2022;58:101450.","journal-title":"Mol Metab"},{"key":"554_CR36","doi-asserted-by":"crossref","unstructured":"Buschhaus JM, Rajendran S, Chen S, Wharram BL, Bevoor AS, Cutter AC, et al. Bone marrow mesenchymal stem cells induce metabolic plasticity in estrogen receptor-positive breast cancer. Mol Cancer Res. 2023;21:458\u201371.","DOI":"10.1158\/1541-7786.MCR-22-0451"},{"key":"554_CR37","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-3-319-55330-6_20","volume":"982","author":"J Cheng","year":"2017","unstructured":"Cheng J, Nanayakkara G, Shao Y, Cueto R, Wang L, Yang WY, et al. Mitochondrial proton leak plays a critical role in pathogenesis of cardiovascular diseases. Adv Exp Med Biol. 2017;982:359\u201370.","journal-title":"Adv Exp Med Biol"},{"key":"554_CR38","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41388-023-02907-z","volume":"43","author":"FR Palma","year":"2024","unstructured":"Palma FR, Gantner BN, Sakiyama MJ, Kayzuka C, Shukla S, Lacchini R, et al. ROS production by mitochondria: function or dysfunction?. Oncogene. 2024;43:295\u2013303.","journal-title":"Oncogene"},{"key":"554_CR39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ab.2017.07.009","volume":"552","author":"LD Zorova","year":"2018","unstructured":"Zorova LD, Popkov VA, Plotnikov EY, Silachev DN, Pevzner IB, Jankauskas SS, et al. Mitochondrial membrane potential. Anal Biochem. 2018;552:50\u201359.","journal-title":"Anal Biochem"},{"key":"554_CR40","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/cr.2018.16","volume":"28","author":"A Melber","year":"2018","unstructured":"Melber A, Haynes CM. UPR(mt) regulation and output: a stress response mediated by mitochondrial-nuclear communication. Cell Res. 2018;28:281\u201395.","journal-title":"Cell Res"},{"key":"554_CR41","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13045-022-01317-0","volume":"15","author":"JR Inigo","year":"2022","unstructured":"Inigo JR, Chandra D. The mitochondrial unfolded protein response (UPR(mt)): shielding against toxicity to mitochondria in cancer. J Hematol Oncol. 2022;15:98.","journal-title":"J Hematol Oncol"},{"key":"554_CR42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40164-022-00303-z","volume":"11","author":"I Oudaert","year":"2022","unstructured":"Oudaert I, Van der Vreken A, Maes A, De Bruyne E, De Veirman K, Vanderkerken K, et al. Metabolic cross-talk within the bone marrow milieu: focus on multiple myeloma. Exp Hematol Oncol. 2022;11:49.","journal-title":"Exp Hematol Oncol"},{"key":"554_CR43","doi-asserted-by":"crossref","unstructured":"Wang L, Yi W, Ma L, Lecea E, Hazlehurst LA, Adjeroh DA, et al. Inflammatory bone marrow mesenchymal stem cells in multiple myeloma: transcriptional signature and in vitro modeling. Cancers (Basel). 2023;15.","DOI":"10.3390\/cancers15215148"},{"key":"554_CR44","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1158\/1078-0432.CCR-11-2212","volume":"18","author":"MR Reagan","year":"2012","unstructured":"Reagan MR, Ghobrial IM. Multiple myeloma mesenchymal stem cells: characterization, origin, and tumor-promoting effects. Clin Cancer Res. 2012;18:342\u20139.","journal-title":"Clin Cancer Res"},{"key":"554_CR45","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.604143","volume":"10","author":"A Barbato","year":"2020","unstructured":"Barbato A, Scandura G, Puglisi F, Cambria D, La Spina E, Palumbo GA, et al. Mitochondrial bioenergetics at the onset of drug resistance in hematological malignancies: an overview. Front Oncol. 2020;10:604143.","journal-title":"Front Oncol"},{"key":"554_CR46","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-15051-z","volume":"11","author":"R Bajpai","year":"2020","unstructured":"Bajpai R, Sharma A, Achreja A, Edgar CL, Wei C, Siddiqa AA, et al. Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma. Nat Commun. 2020;11:1228.","journal-title":"Nat Commun"},{"key":"554_CR47","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-020-02867-2","volume":"11","author":"A Roca-Portoles","year":"2020","unstructured":"Roca-Portoles A, Rodriguez-Blanco G, Sumpton D, Cloix C, Mullin M, Mackay GM, et al. Venetoclax causes metabolic reprogramming independent of BCL-2 inhibition. Cell Death Dis. 2020;11:616.","journal-title":"Cell Death Dis"},{"key":"554_CR48","doi-asserted-by":"crossref","unstructured":"Manni S, Carrino M, Semenzato G, Piazza F. Old and young actors playing novel roles in the drama of multiple myeloma bone marrow microenvironment dependent drug resistance. Int J Mol Sci. 2018;19.","DOI":"10.3390\/ijms19051512"},{"key":"554_CR49","doi-asserted-by":"crossref","first-page":"60698","DOI":"10.18632\/oncotarget.10849","volume":"7","author":"L Di Marzo","year":"2016","unstructured":"Di Marzo L, Desantis V, Solimando AG, Ruggieri S, Annese T, Nico B, et al. Microenvironment drug resistance in multiple myeloma: emerging new players. Oncotarget. 2016;7:60698\u2013711.","journal-title":"Oncotarget"},{"key":"554_CR50","first-page":"301","volume":"44","author":"F Yang","year":"2019","unstructured":"Yang F, Li B, Yang Y, Huang M, Liu X, Zhang Y, et al. Leptin enhances glycolysis via OPA1-mediated mitochondrial fusion to promote mesenchymal stem cell survival. Int J Mol Med. 2019;44:301\u201312.","journal-title":"Int J Mol Med"},{"key":"554_CR51","volume":"9","author":"F Yang","year":"2018","unstructured":"Yang F, Wu R, Jiang Z, Chen J, Nan J, Su S, et al. Leptin increases mitochondrial OPA1 via GSK3-mediated OMA1 ubiquitination to enhance therapeutic effects of mesenchymal stem cell transplantation. Cell Death Dis. 2018;9:556.","journal-title":"Cell Death Dis"},{"key":"554_CR52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cmet.2017.05.016","volume":"26","author":"H Chen","year":"2017","unstructured":"Chen H, Chan DC. Mitochondrial dynamics in regulating the unique phenotypes of cancer and stem cells. Cell Metab. 2017;26:39\u201348.","journal-title":"Cell Metab"},{"key":"554_CR53","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw3835","volume":"379","author":"AP Feinberg","year":"2023","unstructured":"Feinberg AP, Levchenko A. Epigenetics as a mediator of plasticity in cancer. Science. 2023;379:eaaw3835.","journal-title":"Science"},{"key":"554_CR54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31\u201346.","journal-title":"Cancer Discov"},{"key":"554_CR55","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1007\/s00018-019-03199-x","volume":"76","author":"X Wang","year":"2019","unstructured":"Wang X. Stem cells in tissues, organoids, and cancers. Cell Mol Life Sci. 2019;76:4043\u201370.","journal-title":"Cell Mol Life Sci"},{"key":"554_CR56","doi-asserted-by":"crossref","unstructured":"Chu C-H, Tseng W-W, Hsu C-M, Wei A-C. Image analysis of the mitochondrial network morphology with applications in cancer research. Front Phys (Rev). 2022;10.","DOI":"10.3389\/fphy.2022.855775"},{"key":"554_CR57","doi-asserted-by":"crossref","first-page":"H1118","DOI":"10.1152\/ajpheart.00889.2015","volume":"310","author":"R Ochi","year":"2016","unstructured":"Ochi R, Dhagia V, Lakhkar A, Patel D, Wolin MS, Gupte SA. Rotenone-stimulated superoxide release from mitochondrial complex I acutely augments L-type Ca2+ current in A7r5 aortic smooth muscle cells. Am J Physiol Heart Circ Physiol. 2016;310:H1118\u20131128.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"554_CR58","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1177\/1535370218821063","volume":"244","author":"X Feng","year":"2019","unstructured":"Feng X, Zhang W, Yin W, Kang YJ. The involvement of mitochondrial fission in maintenance of the stemness of bone marrow mesenchymal stem cells. Exp Biol Med (Maywood). 2019;244:64\u201372.","journal-title":"Exp Biol Med (Maywood)"},{"key":"554_CR59","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13046-022-02304-6","volume":"41","author":"M Zamberlan","year":"2022","unstructured":"Zamberlan M, Boeckx A, Muller F, Vinelli F, Ek O, Vianello C, et al. Inhibition of the mitochondrial protein Opa1 curtails breast cancer growth. J Exp Clin Cancer Res. 2022;41:95.","journal-title":"J Exp Clin Cancer Res"},{"key":"554_CR60","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13287-022-02758-7","volume":"13","author":"SAA Moqbel","year":"2022","unstructured":"Moqbel SAA, Zeng R, Ma D, Xu L, Lin C, He Y, et al. The effect of mitochondrial fusion on chondrogenic differentiation of cartilage progenitor\/stem cells via Notch2 signal pathway. Stem Cell Res Ther. 2022;13:127.","journal-title":"Stem Cell Res Ther"},{"key":"554_CR61","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0006-2952(02)00863-8","volume":"63","author":"T Gruss-Fischer","year":"2002","unstructured":"Gruss-Fischer T, Fabian I. Protection by ascorbic acid from denaturation and release of cytochrome c, alteration of mitochondrial membrane potential and activation of multiple caspases induced by H(2)O(2), in human leukemia cells. Biochem Pharm. 2002;63:1325\u201335.","journal-title":"Biochem Pharm"},{"key":"554_CR62","first-page":"29","volume":"25","author":"MJ Gonz\u00e1lez","year":"2010","unstructured":"Gonz\u00e1lez MJ, Rosario-P\u00e9rez G, Guzm\u00e1n AM, Miranda-Massari JR, Duconge J, Lavergne J, et al. Mitochondria, energy and cancer: the relationship with ascorbic acid. J Orthomol Med. 2010;25:29\u201338.","journal-title":"J Orthomol Med"},{"key":"554_CR63","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ccell.2018.10.005","volume":"34","author":"CL Jones","year":"2018","unstructured":"Jones CL, Stevens BM, D\u2019Alessandro A, Reisz JA, Culp-Hill R, Nemkov T, et al. Inhibition of amino acid metabolism selectively targets human leukemia stem cells. Cancer Cell. 2018;34:724\u2013740.e724.","journal-title":"Cancer Cell"},{"key":"554_CR64","doi-asserted-by":"crossref","unstructured":"Ibraheem A, Attar-Schneider O, Dabbah M, Dolberg Jarchowsky O, Tartakover Matalon S, Lishner M, et al. BM-MSCs-derived ECM modifies multiple myeloma phenotype and drug response in a source-dependent manner. Transl Res. 2019;207:83\u201395.","DOI":"10.1016\/j.trsl.2019.01.003"},{"key":"554_CR65","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3892\/ijo.2014.2774","volume":"46","author":"V Zismanov","year":"2015","unstructured":"Zismanov V, Attar-Schneider O, Lishner M, Heffez Aizenfeld R, Tartakover Matalon S, Drucker L. Multiple myeloma proteostasis can be targeted via translation initiation factor eIF4E. Int J Oncol. 2015;46:860\u201370.","journal-title":"Int J Oncol"}],"container-title":["Oncogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41389-025-00554-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41389-025-00554-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41389-025-00554-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T12:48:15Z","timestamp":1765802895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41389-025-00554-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["554"],"URL":"https:\/\/doi.org\/10.1038\/s41389-025-00554-5","relation":{},"ISSN":["2157-9024"],"issn-type":[{"value":"2157-9024","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"1 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Funding Note to this article was missing and should have been: This work was supported by the Israel Science Foundation (ISF) Grant (#KM281100126) 2022 and the Varda and Boaz Dotan Research Center for Hemato-Oncology Research Grant (#0601243683) 2019, Tel Aviv University","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures were performed in compliance with relevant laws and institutional guidelines and have been approved by the Meir Medical Center Helsinki Committee (REF: 0205-12-MMC ; REF: 0045-11-MMC). All patients or their guardians\/legally authorized representatives\/next of kin provided written informed consent for participation in the study and the use of samples.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"9"}}